No Prescription |
 |
 | ||
|
Axepta Strattera |
|
| ||
No Prescription » Prescription Drugs 2 » Axepta Strattera Atomoxetine is used as part of a total treatment program to increase the ability to pay attention and decrease impulsiveness and hyperactivity in children and adults with ADHD. Atomoxetine is in a class of medications called selective norepinephrine reuptake inhibitors. It works by increasing the levels of norepinephrine a natural substance in the brain that is needed to control behavior.Atomoxetine comes as a capsule to take by mouth. It is usually taken either once a day in the morning or twice a day in the morning and late afternoon or early evening. Atomoxetine may be taken with or without food. However taking atomoxetine with food may help prevent the medication from upsetting your stomach. Take atomoxetine at around the same time(s) every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take atomoxetine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Swallow atomoxetine capsules whole; do not open chew or crush them. If a capsule is accidentally broken or opened wash away the loose powder with water right away. Try not to touch the powder and be especially careful not to get the powder in your eyes. If you do get powder in your eyes rinse them with water right away and call your doctor.Your doctor will probably start you on a low dose of atomoxetine and increase your dose after at least 3 days. Your doctor may increase your dose again after 2-4 weeks. You may notice improvement in your symptoms during the first week of your treatment but it may take up to one month for you to feel the full benefit of atomoxetine.Atomoxetine may help control the symptoms of ADHD but will not cure the condition. Continue to take atomoxetine even if you feel well. Do not stop taking atomoxetine without talking to your doctor. Buy Axepta Strattera and other Prescription Drugs 2 products online at Medstore. Buy Online at Medstore - Click Here!
About Axepta Strattera: Product Type: Prescription Drugs 2 Axepta ( Strattera Generic Atomoxetine ) Axepta (Strattera Generic Atomoxetine) Strattera Generic Atomoxetine 10MG 100 Tablets 10MG 400(4 x 100) Tablets 10MG 200(2 x 100) Tablets 18MG 100 Tablets 18MG 2 x 100 Tablets 18MG 4 x 100 Tablets 25MG 100 Tablets 25MG 200(2 x 100) Tablets 40MG 200(2 x 100) Tablets 40MG 100 Tablets 60MG 200(2 x 100) Tablets 60MG 100 Tablets Strattera Generic Atomoxetine Axepta
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
